Flutterby™! : Diphenhydramine risks outweigh therapeutic benefits

Next unread comment / Catchup all unread comments User Account Info | Logout | XML/Pilot/etc versions | Long version (with comments) | Weblog archives | Site Map | | Browse Topics

Diphenhydramine risks outweigh therapeutic benefits

2025-05-19 18:23:31.311414+02 by Dan Lyke 0 comments

Yikes: World Allergy Organization Journal: Diphenhydramine: It is time to say a final goodbye

Diphenhydramine is not recommended for people with specific health problems, including closed-angle glaucoma, dry eyes, peptic ulcer, constipation, and urinary retention. In addition, regular use of diphenhydramine poses risks for women who are pregnant or breastfeeding. Due to anticholinergic properties, cumulative use of first-generation antihistamines confers risks for people over age 65, including Alzheimer's disease and other forms of dementia.

Paradoxical stimulation with agitation and confusion is often the presenting sign of harm from first-generation medications in children, followed by extreme sedation and coma. Consuming more than the recommended dose has produced cardiac toxicity because of prolonged QTc and arrhythmias.

Via

[ related topics: Children and growing up Health ]

comments in ascending chronological order (reverse):

Comment policy

We will not edit your comments. However, we may delete your comments, or cause them to be hidden behind another link, if we feel they detract from the conversation. Commercial plugs are fine, if they are relevant to the conversation, and if you don't try to pretend to be a consumer. Annoying endorsements will be deleted if you're lucky, if you're not a whole bunch of people smarter and more articulate than you will ridicule you, and we will leave such ridicule in place.

Flutterby™ is a trademark claimed by

Dan Lyke
for the web publications at www.flutterby.com and www.flutterby.net.